Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Nanoencapsulation of Terfezia Claveryi and Terfezia Boudieri Using Cyclodextrins for Targeted Breast Cancer Therapy

Desert truffles, particularly Terfezia claveryi and Terfezia boudieri, have long attracted scientific interest due to their rich array of bioactive compounds and potential anticancer properties. Yet, despite their promise, their use in treatment protocols is still limited by poor solubility and low...

Full description

Saved in:
Bibliographic Details
Main Author: Nouh, Roua Aref
Format: Thesis
Published: AUC Knowledge Fountain 2026
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1867613432260329472
access_status_str Open Access
author Nouh, Roua Aref
author_browse Nouh, Roua Aref
author_facet Nouh, Roua Aref
author_sort Nouh, Roua Aref
collection Thesis
description Desert truffles, particularly Terfezia claveryi and Terfezia boudieri, have long attracted scientific interest due to their rich array of bioactive compounds and potential anticancer properties. Yet, despite their promise, their use in treatment protocols is still limited by poor solubility and low bioavailability. In this research, we set out to systematically evaluate the anticancer effects of T. claveryi and T. boudieri in breast cancer models, aiming to enhance their therapeutic potential through nanoencapsulation with cyclodextrins and to explore possible synergy with doxorubicin in overcoming drug resistance. To address these goals, the truffles extracts have been encapsulated in hydroxypropyl-β-cyclodextrin (HPβCD), seeking to improve both stability and bioavailability. The cytotoxicity of these formulations was examined via MTT assays on both drug-sensitive (MCF-7) and doxorubicin-resistant (ADR-MCF-7) breast cancer cell lines, across 24, 48, and 72-hour intervals. These assays have been complemented with flow cytometry to analyze apoptosis induction and cell cycle arrest. To take these findings a step further, we had conducted in vivo study in a mouse model, evaluating both systemic toxicity and therapeutic efficacy. The results were  clarified that nanoencapsulation with cyclodextrin led to a more sustained release and markedly improved cytotoxic effects, especially after 72 hours in vitro model. Flow cytometry confirmed significant induction of apoptosis and cell cycle disruption, with nanoformulated extracts consistently outperforming their free counterparts.
format Thesis
id oai:fount.aucegypt.edu:etds-3721
institution American University in Cairo (Egypt)
last_indexed 2026-06-10T12:35:59.828Z
license_str Not specified — see source repository
provenance_str_mv Harvested via OAI-PMH from AUC Knowledge Fountain — bepress
publishDate 2026
publishDateRange 2026
publishDateSort 2026
publisher AUC Knowledge Fountain
publisherStr AUC Knowledge Fountain
record_format dspace
source_str AUC Knowledge Fountain — bepress
spelling oai:fount.aucegypt.edu:etds-3721 Nanoencapsulation of Terfezia Claveryi and Terfezia Boudieri Using Cyclodextrins for Targeted Breast Cancer Therapy Nouh, Roua Aref Desert truffles, particularly Terfezia claveryi and Terfezia boudieri, have long attracted scientific interest due to their rich array of bioactive compounds and potential anticancer properties. Yet, despite their promise, their use in treatment protocols is still limited by poor solubility and low bioavailability. In this research, we set out to systematically evaluate the anticancer effects of T. claveryi and T. boudieri in breast cancer models, aiming to enhance their therapeutic potential through nanoencapsulation with cyclodextrins and to explore possible synergy with doxorubicin in overcoming drug resistance. To address these goals, the truffles extracts have been encapsulated in hydroxypropyl-β-cyclodextrin (HPβCD), seeking to improve both stability and bioavailability. The cytotoxicity of these formulations was examined via MTT assays on both drug-sensitive (MCF-7) and doxorubicin-resistant (ADR-MCF-7) breast cancer cell lines, across 24, 48, and 72-hour intervals. These assays have been complemented with flow cytometry to analyze apoptosis induction and cell cycle arrest. To take these findings a step further, we had conducted in vivo study in a mouse model, evaluating both systemic toxicity and therapeutic efficacy. The results were  clarified that nanoencapsulation with cyclodextrin led to a more sustained release and markedly improved cytotoxic effects, especially after 72 hours in vitro model. Flow cytometry confirmed significant induction of apoptosis and cell cycle disruption, with nanoformulated extracts consistently outperforming their free counterparts. 2026-02-15T08:00:00Z thesis application/pdf https://fount.aucegypt.edu/etds/2723 https://fount.aucegypt.edu/context/etds/article/3721/viewcontent/Roua_Aref_Nouh_Thesis.pdf Theses and Dissertations AUC Knowledge Fountain Desert truffles Terfezia claveryi Terfezia boudieri Nanoencapsulation Cyclodextrin- nano-inclusion complexes Breast cancer cytotoxicity Chemicals and Drugs Diseases Medicine and Health Sciences Pharmacy and Pharmaceutical Sciences
spellingShingle Desert truffles
Terfezia claveryi
Terfezia boudieri
Nanoencapsulation
Cyclodextrin- nano-inclusion complexes
Breast cancer
cytotoxicity
Chemicals and Drugs
Diseases
Medicine and Health Sciences
Pharmacy and Pharmaceutical Sciences
Nouh, Roua Aref
Nanoencapsulation of Terfezia Claveryi and Terfezia Boudieri Using Cyclodextrins for Targeted Breast Cancer Therapy
title Nanoencapsulation of Terfezia Claveryi and Terfezia Boudieri Using Cyclodextrins for Targeted Breast Cancer Therapy
title_full Nanoencapsulation of Terfezia Claveryi and Terfezia Boudieri Using Cyclodextrins for Targeted Breast Cancer Therapy
title_fullStr Nanoencapsulation of Terfezia Claveryi and Terfezia Boudieri Using Cyclodextrins for Targeted Breast Cancer Therapy
title_full_unstemmed Nanoencapsulation of Terfezia Claveryi and Terfezia Boudieri Using Cyclodextrins for Targeted Breast Cancer Therapy
title_short Nanoencapsulation of Terfezia Claveryi and Terfezia Boudieri Using Cyclodextrins for Targeted Breast Cancer Therapy
title_sort nanoencapsulation of terfezia claveryi and terfezia boudieri using cyclodextrins for targeted breast cancer therapy
topic Desert truffles
Terfezia claveryi
Terfezia boudieri
Nanoencapsulation
Cyclodextrin- nano-inclusion complexes
Breast cancer
cytotoxicity
Chemicals and Drugs
Diseases
Medicine and Health Sciences
Pharmacy and Pharmaceutical Sciences
url https://fount.aucegypt.edu/etds/2723
https://fount.aucegypt.edu/context/etds/article/3721/viewcontent/Roua_Aref_Nouh_Thesis.pdf
work_keys_str_mv AT nouhrouaaref nanoencapsulationofterfeziaclaveryiandterfeziaboudieriusingcyclodextrinsfortargetedbreastcancertherapy